OPEN END TURBO LONG - MERCK & CO. | Real-time Bid/Ask 06:15:22 2024-06-20 am EDT | ||
| 3.81 EUR / 3.9 EUR | +1.18% |
|
| Current month | +7.02% | ||
| 1 month | -7.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-06-20 | 3.79 | -0.52% |
| 24-06-19 | 3.81 | -4.75% |
| 24-06-18 | 4 | +3.90% |
| 24-06-17 | 3.85 | -2.78% |
| 24-06-14 | 3.96 | 0.00% |
Delayed Quote Börse Stuttgart
Last update June 20, 2024 at 06:09 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MD5M4B |
| ISIN | DE000MD5M4B4 |
| Date issued | 2022-06-27 |
| Strike | 86.58 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.5 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.39 € |
|---|---|
| Lowest since issue | 0.82 € |
| Spread | 0.09 € |
| Spread % | 2.31% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128
USD
Average target price
142.7
USD
Spread / Average Target
+11.48%
- Stock Market
- Certificates
- Certificat
